Palabras clave
Síndrome de Reye
Varicela
Embarazo
Recién nacido
Anomalías congénitas
Varicela
Embarazo
Recién nacido
Anomalías congénitas
Cómo citar
Fernández-Dulcey, C. A., García Ayala, E., & Pérez, L. A. (2014). Síndrome de Reye congénito asociado a varicela materna. Médicas UIS, 27(3), 113–121. Recuperado a partir de https://revistas.uis.edu.co/index.php/revistamedicasuis/article/view/4891
Resumen
Introducción: el síndrome de Reye es una encefalopatía aguda asociada a una degeneración grasa del hígado que usualmente es precedida de una infección respiratoria o varicela y tiene una alta prevalencia en niños menores de seis años. Objetivo: reportar un caso clínico de síndrome de Reye congénito asociado a la infección por varicela adquirida de la madre. Presentación de caso: se describen los hallazgos de la autopsia, la respectiva correlación clinicopatológica de un recién nacido de sexo masculino de 37 semanas de gestación, hijo de madre con varicela activa desde cuatro días antes del parto, quien presentó súbitamente palidez generalizada, bradicardia y apnea. Resultados: el examen histopatológico encontró en el citoplasma de los hepatocitos y túbulos renales un compromiso vacuolar que correspondía a grasa. En el cerebro se evidenció severo edema, sin inflamación perivascular o meníngea. Conclusión: corresponde a un caso de síndrome de Reye congénito asociado a varicela materna, que terminó manifestándose clínicamente como muerte súbita. Podría ser la primera publicación de un caso de síndrome de Reye congénito asociado a varicela materna. MÉD.UIS. 2014;27(3):113-121.
Referencias
1. Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet. 1963;2:749.
2. Balistreri WF. Reye syndrome and “reye - like” diseases. In: Behrman RE, Kliegman RM, Arvin AM, editors. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: W.B. Saunders Company; 1996. p 1144-5.
3. McGovern M, Glasgow J, Stewart M. Lesson of the week: Reye’s syndrome and aspirin: lest we forget. BMJ. 2001;322:1591-2.
4. Hurwitz ES, Nelson DB, Davis C, Morens D, Schonberger LB. National surveillance for Reye syndrome: A five year review. Pediatrics. 1982;70:895.
5. Trauner DA. Reye’s syndrome [Medical Progress]. West J Med. 1984;141:206-9.
6. Lovejoy FH Jr, Smith AL, Bresnan MJ, Wood JN, Victor DI, Adams PC. Clinical Staging in Reye Syndrome. Am J Dis Child. 1974;128(1):36-41.
7. Huttenlocher PR, Trauner DA. Reye’s syndrome in infancy. Pediatrics. 1978;62(1):84-90.
8. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye’s syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340(18):1377-82.
9. Baldellou A. Síndrome de Reye. Cuarenta años después. An Pediatr (Barc). 2003;59(4):319-22.
10. Daugherty CC. A morphometric study of Reye’s Syndrome. Am J Path. 1987;129:313-6.
11. Weiner DL. Reye síndrome: http://emedicine.medscape.com/ article/803683-overview
12. Benítez L, Pretelt F, Morillo L. Síndrome de Reye: Informe de un caso en adultos. Acta Medica Colombiana. 1992;17(1):63-7.
13. Casteels-Van Daele M, Van Geet C, Wouters C, Eggermont E. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr. 2000;159(9):641-8.
14. Castillo F. Ácido acetilsalicílico y síndrome de Reye. Offarm 2003;22(9):167.
15. Prandota J. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye’s syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther. 2002;9(2):149-56.
16. Schrör K. Aspirin and Reye Syndrome A Review of the Evidence. Pediatr Drugs. 2007;9(3):195-204.
17. Reye syndrome-insights on causation and prognosis. Arch Dis Child. 2001;85:351-3.
18. Mowat AP. Reye’s syndrome and aspirin. In: Vane JR, Botting RM, editors. Aspirin and other salicylates. London: Chapman & Hall Medical. 1992:531-47.
19. Corey L, Rubin RJ, Hattwick MAW, Noble GR, Cassidy E. A nationwide outbreak of Reye’s syndrome: its epidemiologic relationship to influenza B. Am J Med. 1976;61:615-25.
20. Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. Reye’s syndrome and salicylate use. Pediatrics. 1980;66:859-64.
21. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye’s syndrome. JAMA . 1982;247:3089-94.
22. Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Schonberger LB, Fairweather WR, et al. Public Health Service study of Reye’s syndrome and medications: report of the main study. JAMA. 1987;257:1905-11.
23. Duerksen D, Jewell L, Mason A, Bain V. Co-existence of hepatitis A and adult Reye’s. Gut. 1997;41:121-4.
24. Stumpf DA. Reye syndrome: an international perspectiva. Brain & Development. 1995;17(suppI):77-8.
25. Felipo V, Butterworth R. Mitochondrial dysfunction in acute hyperammonemia. Neurochemistry International. 2002;40:487-91.
26. American Academy of Pediatrics. Varicella-zoster Infections. In: Pickering LK, Baker CJ, Long SS, Kimberlin DW, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p.774–89.
27. CDC. Reye Syndrome 1990 Case Definition: wwwn.cdc.gov/nndss/script/casedef.aspx?condyrid=821&datepub=1/1/1990%2012:00:00%20am.
28. Papageorgiou A, Wiglesworth FW, Schiff D, Stern L. Reye’s syndrome in a newborn infant. Can Med Assoc J. 1973;109(8):717-20.
29. National Reye’s Syndrome Foundation. What is Reye’s Syndrome?: http://www.reyessyndrome.org/what.html
30. Quintillá J, Campistol J, Boleda M, Vilaseca M, Artuch R, Palomeque A, et al. Síndrome de Reye-like como manifestación inicial de enfermedad mitocondrial. An Esp Pediatr. 2000;52:479-82.
31. Burton B. Inborn Errors of Metabolism in Infancy: A Guide to Diagnosis. Pediatrics. 1998;102:69.
32. Corrigan J, Watkins L. Hemorrhagic chickenpox associated with disseminated intravascular coagulation. Pediatric Research 1971;5:404–5.
33. American Academy of Pediatrics. Passive immunization. In: Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p.56-69.
34. Ohlsson A, Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2010;17(3):CD001239.
35. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev. 2004;(1):CD000361.
36. Cardona R, Montoya F, Orrego JC. Anafilaxia. Iatreia. 2000;13(1): 16-31.
37. Shearer W, Fleisher T. Constituyent and Development of the Inmune System. In: Middleton E, editors. Alergy: principIes and practice. 5th ed. St Louis: Mosby; 1998. p.2-8.
38. Gold Y, Golderg A, Sivan Y. Hyper-releasability of mast cells in family members of infants with sudden infant death syndrome and apparent life-threatening events. J Pediatr. 2000;136(4):460-5.
39. Weber MA, Ashworth MT, Risdon RA, Brooke I, Malone M, Sebire NJ. Sudden unexpected neonatal death in the first week of life: autopsy findings from a specialist centre. J Matern Fetal Neonatal Med. 2009;22(5):398-404.
2. Balistreri WF. Reye syndrome and “reye - like” diseases. In: Behrman RE, Kliegman RM, Arvin AM, editors. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: W.B. Saunders Company; 1996. p 1144-5.
3. McGovern M, Glasgow J, Stewart M. Lesson of the week: Reye’s syndrome and aspirin: lest we forget. BMJ. 2001;322:1591-2.
4. Hurwitz ES, Nelson DB, Davis C, Morens D, Schonberger LB. National surveillance for Reye syndrome: A five year review. Pediatrics. 1982;70:895.
5. Trauner DA. Reye’s syndrome [Medical Progress]. West J Med. 1984;141:206-9.
6. Lovejoy FH Jr, Smith AL, Bresnan MJ, Wood JN, Victor DI, Adams PC. Clinical Staging in Reye Syndrome. Am J Dis Child. 1974;128(1):36-41.
7. Huttenlocher PR, Trauner DA. Reye’s syndrome in infancy. Pediatrics. 1978;62(1):84-90.
8. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye’s syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340(18):1377-82.
9. Baldellou A. Síndrome de Reye. Cuarenta años después. An Pediatr (Barc). 2003;59(4):319-22.
10. Daugherty CC. A morphometric study of Reye’s Syndrome. Am J Path. 1987;129:313-6.
11. Weiner DL. Reye síndrome: http://emedicine.medscape.com/ article/803683-overview
12. Benítez L, Pretelt F, Morillo L. Síndrome de Reye: Informe de un caso en adultos. Acta Medica Colombiana. 1992;17(1):63-7.
13. Casteels-Van Daele M, Van Geet C, Wouters C, Eggermont E. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr. 2000;159(9):641-8.
14. Castillo F. Ácido acetilsalicílico y síndrome de Reye. Offarm 2003;22(9):167.
15. Prandota J. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye’s syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther. 2002;9(2):149-56.
16. Schrör K. Aspirin and Reye Syndrome A Review of the Evidence. Pediatr Drugs. 2007;9(3):195-204.
17. Reye syndrome-insights on causation and prognosis. Arch Dis Child. 2001;85:351-3.
18. Mowat AP. Reye’s syndrome and aspirin. In: Vane JR, Botting RM, editors. Aspirin and other salicylates. London: Chapman & Hall Medical. 1992:531-47.
19. Corey L, Rubin RJ, Hattwick MAW, Noble GR, Cassidy E. A nationwide outbreak of Reye’s syndrome: its epidemiologic relationship to influenza B. Am J Med. 1976;61:615-25.
20. Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. Reye’s syndrome and salicylate use. Pediatrics. 1980;66:859-64.
21. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye’s syndrome. JAMA . 1982;247:3089-94.
22. Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Schonberger LB, Fairweather WR, et al. Public Health Service study of Reye’s syndrome and medications: report of the main study. JAMA. 1987;257:1905-11.
23. Duerksen D, Jewell L, Mason A, Bain V. Co-existence of hepatitis A and adult Reye’s. Gut. 1997;41:121-4.
24. Stumpf DA. Reye syndrome: an international perspectiva. Brain & Development. 1995;17(suppI):77-8.
25. Felipo V, Butterworth R. Mitochondrial dysfunction in acute hyperammonemia. Neurochemistry International. 2002;40:487-91.
26. American Academy of Pediatrics. Varicella-zoster Infections. In: Pickering LK, Baker CJ, Long SS, Kimberlin DW, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p.774–89.
27. CDC. Reye Syndrome 1990 Case Definition: wwwn.cdc.gov/nndss/script/casedef.aspx?condyrid=821&datepub=1/1/1990%2012:00:00%20am.
28. Papageorgiou A, Wiglesworth FW, Schiff D, Stern L. Reye’s syndrome in a newborn infant. Can Med Assoc J. 1973;109(8):717-20.
29. National Reye’s Syndrome Foundation. What is Reye’s Syndrome?: http://www.reyessyndrome.org/what.html
30. Quintillá J, Campistol J, Boleda M, Vilaseca M, Artuch R, Palomeque A, et al. Síndrome de Reye-like como manifestación inicial de enfermedad mitocondrial. An Esp Pediatr. 2000;52:479-82.
31. Burton B. Inborn Errors of Metabolism in Infancy: A Guide to Diagnosis. Pediatrics. 1998;102:69.
32. Corrigan J, Watkins L. Hemorrhagic chickenpox associated with disseminated intravascular coagulation. Pediatric Research 1971;5:404–5.
33. American Academy of Pediatrics. Passive immunization. In: Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p.56-69.
34. Ohlsson A, Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2010;17(3):CD001239.
35. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev. 2004;(1):CD000361.
36. Cardona R, Montoya F, Orrego JC. Anafilaxia. Iatreia. 2000;13(1): 16-31.
37. Shearer W, Fleisher T. Constituyent and Development of the Inmune System. In: Middleton E, editors. Alergy: principIes and practice. 5th ed. St Louis: Mosby; 1998. p.2-8.
38. Gold Y, Golderg A, Sivan Y. Hyper-releasability of mast cells in family members of infants with sudden infant death syndrome and apparent life-threatening events. J Pediatr. 2000;136(4):460-5.
39. Weber MA, Ashworth MT, Risdon RA, Brooke I, Malone M, Sebire NJ. Sudden unexpected neonatal death in the first week of life: autopsy findings from a specialist centre. J Matern Fetal Neonatal Med. 2009;22(5):398-404.
Descargas
Los datos de descargas todavía no están disponibles.